Aptahem AB (publ) (NGM:APTA)
0.8960
-0.0300 (-3.24%)
At close: Feb 26, 2026
Aptahem AB Revenue
In the year 2025, Aptahem AB had annual revenue of 2.59M SEK, down -31.47%. Aptahem AB had revenue of 829.00K in the quarter ending December 31, 2025, a decrease of -64.84%.
Revenue
2.59M
Revenue Growth
-31.47%
P/S Ratio
7.27
Revenue / Employee
861.67K
Employees
3
Market Cap
18.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.59M | -1.19M | -31.47% |
| Dec 31, 2024 | 3.77M | -6.69M | -63.95% |
| Dec 31, 2023 | 10.46M | 7.02M | 203.47% |
| Dec 31, 2022 | 3.45M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanologica AB | 22.65M |
| Fluicell AB | 15.51M |
| ExpreS2ion Biotech Holding AB | 10.85M |
| AcouSort AB | 10.80M |
| 2cureX AB | 1.98M |
| Pila Pharma AB | 1.13M |
| NanoEcho AB | 487.00K |
| Novakand Pharma AB | 14.00K |